These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 18287163

  • 21. Microcirculatory dysfunction in chronic venous insufficiency (CVI).
    Jünger M, Steins A, Hahn M, Häfner HM.
    Microcirculation; 2000; 7(6 Pt 2):S3-12. PubMed ID: 11151969
    [Abstract] [Full Text] [Related]

  • 22. Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency.
    Cesarone MR, Belcaro G, Pellegrini L, Ledda A, Vinciguerra G, Ricci A, Di Renzo A, Ruffini I, Gizzi G, Ippolito E, Fano F, Dugall M, Acerbi G, Cornelli U, Hosoi M, Cacchio M.
    Angiology; 2006; 57(2):131-8. PubMed ID: 16518519
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prevention of edema and flight microangiopathy with Venoruton (HR), (0-[beta-hydroxyethyl]-rutosides) in patients with varicose veins.
    Cesarone MR, Belcaro G, Ricci A, Brandolini R, Pellegrini L, Dugall M, Di Renzo A, Vinciguerra G, Gizzi G, Cornelli U, Errichi BM, Corsi M, Ippolito E, Adovasio R, Cacchio M, Stuard S, Larnier C, Candiani C, Cerritelli F.
    Angiology; 2005; 56(3):289-93. PubMed ID: 15889196
    [Abstract] [Full Text] [Related]

  • 26. Microcirculatory effects of total triterpenic fraction of Centella asiatica in chronic venous hypertension: measurement by laser Doppler, TcPO2-CO2, and leg volumetry.
    Cesarone MR, Belcaro G, Rulo A, Griffin M, Ricci A, Ippolito E, De Sanctis MT, Incandela L, Bavera P, Cacchio M, Bucci M.
    Angiology; 2001 Oct; 52 Suppl 2():S45-8. PubMed ID: 11666123
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial.
    Belcaro G, Cesarone MR, Bavera P, Ricci A, Renton S, Leon M, Ippolito E, Dugall M, Acerbi G.
    J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):139-45. PubMed ID: 12232562
    [Abstract] [Full Text] [Related]

  • 29. Treatment of diabetic microangiopathy and edema with total triterpenic fraction of Centella asiatica: a prospective, placebo-controlled randomized study.
    Incandela L, Belcaro G, Cesarone MR, De Sanctis MT, Nargi E, Patricelli P, Bucci M.
    Angiology; 2001 Oct; 52 Suppl 2():S27-31. PubMed ID: 11666119
    [Abstract] [Full Text] [Related]

  • 30. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
    Andreozzi GM.
    Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
    [Abstract] [Full Text] [Related]

  • 31. Acute effects of TTFCA on capillary filtration in severe venous hypertension.
    De Sanctis MT, Incandela L, Cesarone MR, Grimaldi R, Belcaro G, Marelli C.
    Panminerva Med; 1994 Jun; 36(2):87-90. PubMed ID: 7831065
    [Abstract] [Full Text] [Related]

  • 32. Variations in plasma free radicals in patients with venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized trial.
    Cesarone MR, Incandela L, DeSanctis MT, Belcaro G, Dugall M, Acerbi G.
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S25-8. PubMed ID: 12011970
    [Abstract] [Full Text] [Related]

  • 33. Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease.
    Flota-Cervera F, Flota-Ruiz C, Treviño C, Berber A.
    Angiology; 2008 Jan; 59(3):352-6. PubMed ID: 18388097
    [Abstract] [Full Text] [Related]

  • 34. Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency.
    Rehn D, Unkauf M, Klein P, Jost V, Lücker PW.
    Arzneimittelforschung; 1996 May; 46(5):483-7. PubMed ID: 8737631
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
    Cappelli R, Pecchi S, Oberhauser V, Forconi S, Di Perri T.
    Int J Clin Pharmacol Res; 1987 May; 7(4):291-9. PubMed ID: 3596872
    [Abstract] [Full Text] [Related]

  • 36. HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial.
    Incandela L, Belcaro G, Renton S, DeSanctis MT, Cesarone MR, Bavera P, Ippolito E, Bucci M, Griffin M, Geroulakos G, Dugall M, Golden G, Acerbi G.
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S7-S10. PubMed ID: 12011966
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Flight microangiopathy in medium-to-long distance flights: prevention of edema and microcirculation alterations with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a prospective, randomized, controlled trial.
    Cesarone MR, Belcaro G, Incandela L, Geroulakos G, Griffin M, Lennox A, DeSanctis MT, Acerbi G.
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S17-20. PubMed ID: 12011968
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Microangiopathy of cutaneous blood and lymphatic capillaries in chronic venous insufficiency (CVI).
    Franzeck UK, Haselbach P, Speiser D, Bollinger A.
    Yale J Biol Med; 1993 Jan; 66(1):37-46. PubMed ID: 8256463
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.